These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38532103)

  • 1. Identification of unique rectal cancer-specific subtypes.
    Kisakol B; Matveeva A; Salvucci M; Kel A; McDonough E; Ginty F; Longley DB; Prehn JHM
    Br J Cancer; 2024 May; 130(11):1809-1818. PubMed ID: 38532103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling.
    Liu H; Zhang Z; Zhen P; Zhou M
    J Immunol Res; 2021; 2021():6657012. PubMed ID: 33506057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
    Svoboda M; Sana J; Fabian P; Kocakova I; Gombosova J; Nekvindova J; Radova L; Vyzula R; Slaby O
    Radiat Oncol; 2012 Nov; 7():195. PubMed ID: 23167930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
    Li CF; He HL; Wang JY; Huang HY; Wu TF; Hsing CH; Lee SW; Lee HH; Fang JL; Huang WT; Chen SH
    J Clin Pathol; 2014 Dec; 67(12):1056-61. PubMed ID: 25271212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of oncogenesis in colon versus rectal cancer.
    Kapiteijn E; Liefers GJ; Los LC; Kranenbarg EK; Hermans J; Tollenaar RA; Moriya Y; van de Velde CJ; van Krieken JH
    J Pathol; 2001 Sep; 195(2):171-8. PubMed ID: 11592095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
    Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
    Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic Analyses of Pretreatment Tumor Biopsy Samples, Response to Neoadjuvant Chemoradiotherapy, and Survival in Patients With Advanced Rectal Cancer.
    Akiyoshi T; Wang Z; Kaneyasu T; Gotoh O; Tanaka N; Amino S; Yamamoto N; Kawachi H; Mukai T; Hiyoshi Y; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Noda T; Mori S
    JAMA Netw Open; 2023 Jan; 6(1):e2252140. PubMed ID: 36662520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa.
    Gaedcke J; Grade M; Camps J; Søkilde R; Kaczkowski B; Schetter AJ; Difilippantonio MJ; Harris CC; Ghadimi BM; Møller S; Beissbarth T; Ried T; Litman T
    Clin Cancer Res; 2012 Sep; 18(18):4919-30. PubMed ID: 22850566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global DNA methylation is altered by neoadjuvant chemoradiotherapy in rectal cancer and may predict response to treatment - A pilot study.
    Tsang JS; Vencken S; Sharaf O; Leen E; Kay EW; McNamara DA; Deasy J; Mulligan ED
    Eur J Surg Oncol; 2014 Nov; 40(11):1459-66. PubMed ID: 25108814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.
    Lin CY; Hsieh PL; Chou CL; Yang CC; Lee SW; Tian YF; Shiue YL; Li WS
    Oncology; 2020; 98(8):549-557. PubMed ID: 32408308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in gene expression profiles and carcinogenesis pathways between colon and rectal cancer.
    Li JN; Zhao L; Wu J; Wu B; Yang H; Zhang HH; Qian JM
    J Dig Dis; 2012 Jan; 13(1):24-32. PubMed ID: 22188913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should rectal cancer located 10-15 cm from the anal verge be defined as colon cancer.
    Swets M; Breugom AJ; Gelderblom H; van de Velde CJH
    Ann Oncol; 2017 Mar; 28(3):664-665. PubMed ID: 27836884
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patients.
    Yasui K; Kondou R; Iizuka A; Miyata H; Tanaka E; Ashizawa T; Nagashima T; Ohshima K; Urakami K; Kusuhara M; Muramatsu K; Sugino T; Yamguchi K; Mori K; Harada H; Nishimura T; Kagawa H; Yamakawa Y; Hino H; Shiomi A; Akiyama Y
    J Radiat Res; 2020 Sep; 61(5):766-775. PubMed ID: 32672335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53.
    Chiorean EG; Sanghani S; Schiel MA; Yu M; Burns M; Tong Y; Hinkle DT; Coleman N; Robb B; LeBlanc J; Clark R; Bufill J; Curie C; Loehrer PJ; Cardenes H
    Cancer Chemother Pharmacol; 2012 Jul; 70(1):25-32. PubMed ID: 22610353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of epithelial mesenchymal transition and resistance to neoadjuvant therapy in locally advanced rectal cancer.
    Bhangu A; Wood G; Brown G; Darzi A; Tekkis P; Goldin R
    Colorectal Dis; 2014 Apr; 16(4):O133-43. PubMed ID: 24617665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of LGR5 and CD44 expression in locally advanced rectal cancer after preoperative chemoradiotherapy.
    Saigusa S; Inoue Y; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Uchida K; Mohri Y; Kusunoki M
    Int J Oncol; 2012 Nov; 41(5):1643-52. PubMed ID: 22923071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
    Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
    Li M; Li JY; Zhao AL; Gu J
    Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy.
    Schwaab J; Horisberger K; Ströbel P; Bohn B; Gencer D; Kähler G; Kienle P; Post S; Wenz F; Hofmann WK; Hofheinz RD; Erben P
    BMC Cancer; 2011 Aug; 11():363. PubMed ID: 21854597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis.
    Ho V; Chung L; Singh A; Lea V; Abubakar A; Lim SH; Ng W; Lee M; de Souza P; Shin JS; Lee CS
    BMC Cancer; 2018 Sep; 18(1):869. PubMed ID: 30176843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.